Eikon Therapeutics Continues the IPO Parade, Raising $381M for Cancer Drug Clinical Trials

Eikon Therapeutics’ IPO haul will support a lead program that could expand the scope of cancer immunotherapy. Eikon’s stock market debut builds on growing IPO momentum, following upsized offerings from Aktis Oncology and Veradermics. The post Eikon Therapeutics Continues the IPO Parade, Raising $381M for Cancer Drug Clinical Trials appeared first on MedCity News.

Read More

What is Project IDEATE?

How best can you design an outcomes based agreement (OBA)? What are the key factors to consider? Project IDEATE is a “cross-disciplinary collaboration between National Health Service (NHS) Wales, industry and academia” with the aim to develop and refine OBA models. What were the key factors IDEATE considered for an OBA? Feasibility: Identify parameters to…

Read More

Startup Raises $7M for Virtual-First Pediatric Therapy Model

Ladder Health’s seed round was led by Nina Capital, with participation from Mairs & Power Venture Capital, South Dakota First Capital, 25madison Health, Hatteras Venture Partners, Create Health Ventures, Jumpstart Capital, White Oak Enterprises, Groove Capital and 7Rock Ventures. The post Startup Raises $7M for Virtual-First Pediatric Therapy Model appeared first on MedCity News.

Read More